RNS Number : 7279Q
Legal & General UCITS ETF PLC
23 June 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
22/06/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
137835726.42 |
11.713 |
| L&G UK Equity UCITS ETF |
22/06/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
11100040.51 |
9.250 |
| L&G Global Equity UCITS ETF |
22/06/2020 |
IE00BFXR5S54 |
2900000 |
USD |
32768069.48 |
11.299 |
| L&G Japan Equity UCITS ETF |
22/06/2020 |
IE00BFXR5T61 |
11085000 |
USD |
117823697.14 |
10.629 |
| L&G Europe ex UK Equity UCITS ETF |
22/06/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
100276761.55 |
10.712 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
22/06/2020 |
IE00BFXR5W90 |
4505639 |
USD |
46628573.42 |
10.349 |
| L&G Clean Water UCITS ETF |
22/06/2020 |
IE00BK5BC891 |
1500000 |
USD |
15459730.98 |
10.306 |
| L&G Artificial Intelligence UCITS ETF |
22/06/2020 |
IE00BK5BCD43 |
6246000 |
USD |
78891648.10 |
12.631 |
| L&G Healthcare Innovation UCITS ETF |
22/06/2020 |
IE00BK5BC677 |
2600000 |
USD |
32730915.93 |
12.589 |
| L&G Pharma Breakthrough UCITS ETF |
22/06/2020 |
IE00BF0H7608 |
2500000 |
USD |
30226545.72 |
12.091 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
22/06/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
93278606.87 |
10.139 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
22/06/2020 |
IE00BKLWY790 |
57400000 |
USD |
604019014.52 |
10.523 |
| L&G Battery Value-Chain UCITS ETF |
22/06/2020 |
IE00BF0M2Z96 |
11750000 |
USD |
108568797.41 |
9.240 |
| L&G Ecommerce Logistics UCITS ETF |
22/06/2020 |
IE00BF0M6N54 |
5500000 |
USD |
58200157.32 |
10.582 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
22/06/2020 |
IE00BMW3QX54 |
47330616 |
USD |
809232297.96 |
17.097 |
| L&G Cyber Security UCITS ETF |
22/06/2020 |
IE00BYPLS672 |
85111776 |
USD |
1606891787.09 |
18.880 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVGZGZVFZRGGZZ
